Trends in the prescription of novel oral anticoagulants in UK primary care
ConclusionsIn the UK, the initiation of NOAC has increased substantially since 2009, and NOAC have now surpassed VKA as the anticoagulant of choice. Moreover, the characteristics of patients initiated on NOAC have changed over time, and this should be accounted for in future studies comparing NOAC and VKA.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: S. Y. Loo, S. Dell'Aniello, L. Huiart, C. Renoux Tags: PHARMACOEPIDEMIOLOGY Source Type: research
More News: Cardiology | Congestive Heart Failure | Drugs & Pharmacology | Heart | Heart Failure | Ischemic Stroke | Peripheral Vascular Disease (PVD) | Pradaxa | Primary Care | Stroke | Study | Thrombosis